157 related articles for article (PubMed ID: 10406235)
1. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.
Havelund T; Lind T; Wiklund I; Glise H; Hernqvist H; Lauritsen K; Lundell L; Pedersen SA; Carlsson R; Junghard O; Stubberöd A; Anker-Hansen O
Am J Gastroenterol; 1999 Jul; 94(7):1782-9. PubMed ID: 10406235
[TBL] [Abstract][Full Text] [Related]
2. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
[TBL] [Abstract][Full Text] [Related]
3. Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.
Wiklund I; Carlsson R; Carlsson J; Glise H
Scand J Gastroenterol; 2006 Mar; 41(3):288-93. PubMed ID: 16497615
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
Levin TR; Sperling RM; McQuaid KR
Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
[TBL] [Abstract][Full Text] [Related]
5. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
Richter JE; Kahrilas PJ; Sontag SJ; Kovacs TO; Huang B; Pencyla JL
Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
Revicki DA; Sorensen S; Maton PN; Orlando RC
Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
[TBL] [Abstract][Full Text] [Related]
10. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.
Lind T; Havelund T; Carlsson R; Anker-Hansen O; Glise H; Hernqvist H; Junghard O; Lauritsen K; Lundell L; Pedersen SA; Stubberöd A
Scand J Gastroenterol; 1997 Oct; 32(10):974-9. PubMed ID: 9361168
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
Bigard MA; Genestin E
Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
[TBL] [Abstract][Full Text] [Related]
12. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
14. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux.
Moore DJ; Tao BS; Lines DR; Hirte C; Heddle ML; Davidson GP
J Pediatr; 2003 Aug; 143(2):219-23. PubMed ID: 12970637
[TBL] [Abstract][Full Text] [Related]
15. The ambulatory pH study is normal, but the patient is not--the importance of the symptoms index.
Katz P
Am J Gastroenterol; 1998 Jan; 93(1):129-31. PubMed ID: 9448198
[No Abstract] [Full Text] [Related]
16. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
17. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.
Galmiche JP; Barthelemy P; Hamelin B
Aliment Pharmacol Ther; 1997 Aug; 11(4):765-73. PubMed ID: 9305487
[TBL] [Abstract][Full Text] [Related]
18. Measuring improved quality of life after laparoscopic Nissen fundoplication.
Rattner DW
Surgery; 2000 Mar; 127(3):258-63. PubMed ID: 10715979
[TBL] [Abstract][Full Text] [Related]
19. Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.
Junghard O; Wiklund IK
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):555-60. PubMed ID: 17556901
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
